Ann Am Thorac Soc
Ann Am Thorac Soc
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
107
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 107 PapersIndoor Air Sources of Outdoor Air Pollution: Health Consequences, Policy, and Recommendations: An Official American Tho…
Nassikas NJ, McCormack MC, Ewart G, Balmes JR, Bond TC, Brigham E, Cromar K, Goldstein AH, Hicks A,…
Providing Cleaning Recommendations for Positive Airway Pressure Devices.
Patel SR.
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data.
Vaeli Zadeh A, Dinparastisaleh R, Vaezi A, Bandyopadhyay D, Rubinstein I, Baig HZ, Calderon-Candela…
Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Association.
Coston TD, Wright SW, Phunpang R, Dulsuk A, Thiansukhon E, Chaisuksant S, Tanwisaid K, Chuananont S…
Survival and Long-Term Functional Status of COVID-19 Patients Requiring Prolonged Extracorporeal Membrane Oxygenation S…
Martínez-Martínez M, Schmidt M, Broman LM, Roncon-Albuquerque R, Langouet E, Campos I, Argudo E, Do…
Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE.
Criner GJ, Mallea JM, Abu-Hijleh M, Sachdeva A, Kalhan R, Hergott CA, Lazarus DR, Mularski RA, Cale…
Building Career Paths for Ph.D., Basic and Translational Scientists in Clinical Departments in the United States: An Of…
Moore BB, Ballinger MN, Bauer NN, Blackwell TS, Borok Z, Budinger GRS, Camoretti-Mercado B, Erzurum…
Burnout and Turnover Intention in Critical Care Professionals During the COVID-19 Pandemic in Japan: A Cross-sectional …
Kuriyama A, Sakuraya M, Kinjo M, Santanda T, Yoshino T, Ouchi K, Suyama S, Yoshino S, Saito S, Yoko…
Dose-Response Relationship between Obstructive Sleep Apnea Therapy Adherence and Healthcare Utilization.
Malhotra A, Sterling KL, Cistulli PA, Pépin JL, Chen J, Woodford C, Alpert N, More S, Nunez CM, Ben…
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous …
Stahl M, Roehmel J, Eichinger M, Doellinger F, Naehrlich L, Kopp MV, Dittrich AM, Lee C, Sommerburg…